Ruder Finn has acquired Mantis, a British medtech company that targets companies operating in the public sector.
Mantis has a dozen staffers who counsel 23 clients, 85 percent of which work with the National Health Service, social care providers and private healthcare sectors.
Eleanor Willock, managing director at Mantis, said her firm brings “the stories of life-changing technology powering public services to industry and consumer attention.”
Ruder Finn has momentum in the medtech space and has been looking for the right partner to take it to the next level, according to Nick Leonard, UK MD at the independent shop.
“Many agencies claim to target the MedTech space but very few will have the clinical and technical credentials and capabilities of our combined proposition,” he added.
Ruder Finn ranks No. 6 in O’Dwyer’s rankings of independent PR firms with 2020 fees of $87.8M.